Med Tech Home»Raj Bawa's Profile

Raj Bawa's Profile

General
Raj Bawa Raj Bawa , USA
About me : Dr. Raj Bawa is President of Bawa Biotechnology Consulting LLC, a biotechnology and patent law firm founded in 2002 and based in Ashburn, Virginia. He is a biochemist and microbiologist by training as well as a registered patent agent licensed to practice before the US Patent and Trademark Office (PTO). He specializes in all aspects of biotechnology, nanotechnology and pharmaceutical patent law, including prosecution, patent strategy, application drafting, prior art searching, freedom-to-operate searching and technology research opinions. Currently, Dr. Bawa is an Adjunct Professor at Rensselaer Polytechnic Institute in Troy, New York as well as an Adjunct Professor of Natural and Applied Sciences at the Extended Learning Institute of Northern Virginia Community College in Annandale, Virginia. He is the Principle Investigator of two National Cancer Institute/SBIR contracts titled "A Targeted Nanocomplex for Early Detection of Lung Cancer" and "Targeted Nanocomplexed Iron Oxide for Early Detection with Concurrent Hyperthermia Treatment of Cancer" respectively. Previously he held various positions at the PTO, including Primary Examiner (6 years); Supervisory Patent Examiner (acting); and Instructor at the US Patent Academy. Dr. Bawa has served as an NIH grant reviewer and participated in NSF's merit review process. He has authored 60 scientific, legal and business publications and has presented at over 100 conferences and symposia worldwide. He is a Life Member of Sigma Xi, Founding Director of the American Society for Nanomedicine, Advisory Board member of the Lifeboat Foundation and serves on the Global Advisory Council of the World Future Society. Presently, Dr Bawa serves on the editorial boards of the following peer-reviewed journals: International Journal of Nanomedicine, Cancer Nanotechnology: Basic, Translational and Clinical Research, Recent Patents on Biomedical Engineering, Recent Patents on Nanotechnology, Nanotechnology Law and Business, WIRE's Nanomedicine and Nanobiotechnology. He is an Associate Editor of two peer-reviewed journals, Journal of Bionanoscience and Nanomedicine: NBM. He is Editor for The Pan Stanford Clinical Nanomedicine Series (Pan Stanford Publishing, 2012 onwards); "Nanotechnology – Law, Business and Commercialization" (Pan Stanford Publishing, 2012) and the Section Editor of the "Biomedical Engineering Handbook, 4th edition" (CRC Press/Taylor Francis, 2012). His biographical record appears in the 2010 edition of Marquis Who's Who in the World. Some of Dr. Bawa's awards include: Innovations Prize from the Institution of Mechanical Engineers, London, UK (2008); Appreciation Award from the Undersecretary of Commerce, Washington, DC (2001); Research Fellowship and Teaching Assistantship from Rensselaer (1985-90); Director's Award (2001) and Key Award (2005) from Rensselaer's Office of Alumni Relations.
 
Current Profession
NA
Company : NA
 
Recent and Popular Contributions
  • Regulating Nanomedicine - Can the FDA handle it? (2011) (Reads:769, Saved 0 Time(s))
    (see paper)...
  • Regulating Nanomedicine – Can the FDA handle it? (Reads:872, Saved 0 Time(s))
    There are no specific laws or mechanisms are in place for oversight of nanomedicine. The FDA should not attempt regulation of nanomedicine by applying existing statutes alone, especially where scientific evidence suggests otherwise. Incorporating nanomed...
  • Regulating Nanomedicine – Can the FDA handle it (Reads:1915, Saved 0 Time(s))
    Evidence continues to mount that many nanoproducts inherently posses novel size-based properties and toxicity profiles. Yet, there is no specific law or mechanism for oversight of nanomedicine and the FDA continues to treat nanoproducts as substantially ...
  • The carbon nanotube patent (Reads:776, Saved 1 Time(s))
    Carbon nanotubes (CNTs) have extraordinary properties that make them promising candidates for a wide variety of potential biomedical applications, including new therapeutics, drug delivery systems and diagnostics. Because of their enormous commercial p...
  • Nanopharmaceuticals (Reads:1175, Saved 0 Time(s))
    ....
  • Nanopharmaceuticals (Reads:939, Saved 0 Time(s))
    ....
  • Nanopharmaceuticals - A Review (Reads:1712, Saved 1 Time(s))
    There is enormous excitement and expectation surrounding the multidisciplinary field of nanotechnology. This carries over to nanomedicine – the application of nanotechnology to healthcare – which is already influencing the pharmaceutical industry, especi...
  • Nanopharmaceuticals - Patenting Issues and FDA Regulatory Challenges (Reads:1995, Saved 0 Time(s))
 
weSRCH is the world's largest networking site for professionals.
weSRCH being a unique site exclusively designed for high-end professionals looks forward towards bridging the gap between real and virtual world. Enabling social interaction with various other scientists, doctors, engineers, and colleagues in your field, weSRCH keeps you abreast of latest ongoing in the field of High-tech, Green-tech, Medicine and Business. Register free to be a member!

Looking for a professional platform? weSRCH is an all-in-one virtual science networking stage. Create your profile and share Reports, NewsFeed, Research papers and much more. Stay connected, for a better career prospect